The category includes growth hormone secretagogues like CJC-1295 and ipamorelin, immune-modulating peptides like thymosin alpha-1, and metabolic regulators that overlap with the GLP-1 class of compounds used in programs like GLP-1 Longevity Care
Requires fewer injections than prolotherapy
Important Notice: BPC-157 and TB-500 are not approved by the Therapeutic Goods Administration (TGA) in Australia for general therapeutic use
[2] If you experience concerning symptoms after an injection, seek medical advice and consider reporting suspected side effects through the MHRA Yellow Card scheme
While the product itself dissolves, the collagen it stimulates remains, which is why results can last for an extended period
Patients with vegan diets, post-bariatric history, or absorption challenges who need consistent repletion